This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,122.40, is a Firm Fixed Price Delivery Order with a completion date of June 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a pharmaceutical product, with a ceiling value of $2,265.29. The award date is November 27, 2023, and the ultimate completion date is December 18, 2023. This is not a set-aside contract. AmerisourceBergen holds a $999,999,999...
This contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, with a ceiling value of $2,265.29 and a completion date of August 15, 2024. The contract is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,326.45, is for the supply of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,530.60 Firm Fixed Price Delivery Order contract was awarded by the Defense Logistics Agency (DLA), with an ultimate completion date of December 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a medical product, with a ceiling value of $6,795.87 and a performance period through August 7, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a $2,343.59 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides the TEZSPIRE 210 MG/1.91 ML PEN 1.91ML medication with an ultimate completion date of April 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a medical product, with a ceiling value of $46,871.80 and an ultimate completion date of March 11, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a larger Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,030.77 and an ultimate completion date of March 6, 2025. The order is for the medical product "TEZSPIRE 210 MG/1.91 ML PEN 1.91ML" and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999...
This federal contract award is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a ceiling value of $4,687.18. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 11, 2025. The contract is not designated with a set-aside requirement,...